What is Retatrutide?
Retatrutide is an investigational triple agonist acting on GIP, GLP-1 and glucagon receptors, studied for its potential effects on energy expenditure and body weight.

Branded vial mockup · packaging may vary
Triple GIP/GLP-1/glucagon agonist
The triple-threat of next-gen metabolic research.
Individual
$24.15
per vial · Currently unavailable
$24.15 · individual vials
Fast USA shipping
Payments not yet available
Card payments unavailable
Retatrutide is an investigational triple agonist acting on GIP, GLP-1 and glucagon receptors, studied for its potential effects on energy expenditure and body weight.
Enter your numbers and get the matching volume and syringe marking.
Concentration
5 mg/mL
Full draws per vial
5
Math from the values you enter only. Double-check your inputs and syringe markings. For laboratory measurement; not dosing advice.
Follow the storage conditions supplied for your specific material and batch.
Use a validated laboratory protocol and a compatible solvent. The calculator checks arithmetic, not solvent suitability.
Follow compound-specific stability data. A universal storage temperature or shelf life cannot be inferred.
It targets three receptors — GIP, GLP-1 and glucagon — in one molecule.